MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients

Clinical trial NCT06308926 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06308926
Sponsor: MedRegen LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Respiratory Failure Respiratory Distress Syndrome Respiratory Tract Diseases Cytokine Storm

Start date: 2024-12-01
Primary completion: 2026-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.